210 ILCS 25/2-131
210 ILCS 25/2-131
in effect(210 ILCS 25/2-131) (from Ch. 111 1/2, par. 622-131) Sec. 2-131. "Industrial use" means a use of blood in which the blood is modified by physical or chemical means to produce derivatives for therapeutic or pharmaceutic biologicals and laboratory reagents or controls. (Source: P.A. 87-1269.)
Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://www.ilga.gov/legislation/ilcs/ilcs.aspFetched: 10/17/2026
